UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis C virus core antigen testing: Role in diagnosis, disease monitoring and treatment

World journal of gastroenterology : WJG, 2014-06, Vol.20 (22), p.6701-6706

Tillmann, Hans L

2014

Volltextzugriff (PDF)

A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)

PloS one, 2022-09, Vol.17 (9), p.e0271304

2022

Volltextzugriff (PDF)

HLA‐B35:01 and Green Tea–Induced Liver Injury

Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2484-2493

2021

Volltextzugriff (PDF)

Death and liver transplantation within 2 years of onset of drug‐induced liver injury

Hepatology (Baltimore, Md.), 2017-10, Vol.66 (4), p.1275-1285

2017

Volltextzugriff (PDF)

Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin

Gastroenterology (New York, N.Y. 1943), 2010-06, Vol.138 (7), p.2307-2314

2010

Volltextzugriff (PDF)

Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury

Gastroenterology (New York, N.Y. 1943), 2011-11, Vol.141 (5), p.1665-1672.e9

2011

Volltextzugriff (PDF)

Antiviral therapy and resistance with hepatitis B virus infection

World journal of gastroenterology : WJG, 2007-01, Vol.13 (1), p.125

Tillmann, Hans L

2007

Volltextzugriff (PDF)

Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia and Decrease the Need for Ribavirin Dose Reduction

Gastroenterology (New York, N.Y. 1943), 2010-10, Vol.139 (4), p.1181-1189.e2

2010

Volltextzugriff (PDF)

It's not all about the virus-On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B

Hepatology (Baltimore, Md.), 2023-02, Vol.77 (2), p.352-n/a

2023

Volltextzugriff (PDF)

Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence

Antiviral therapy, 2008-01, Vol.13 (2), p.211-220

2008

Volltextzugriff (PDF)

Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis

The FASEB journal, 2002-07, Vol.16 (9), p.935-942

2002

Volltextzugriff (PDF)

Therapy of Acute and Fulminant Hepatitis B

Intervirology, 2014-01, Vol.57 (3-4), p.181-188

2014

Volltextzugriff (PDF)

Trends in mortality from gastrointestinal, hepatic, and pancreatic cancers in the United States: A comprehensive analysis (1999–2020)

JGH open, 2024-04, Vol.8 (4), p.e13064-n/a

2024

Volltextzugriff (PDF)

Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy

Digestive diseases and sciences, 2023-12, Vol.68 (12), p.4511-4520

2023

Volltextzugriff (PDF)

Role of Hepatitis B Surface Antibodies in Risk for Hepatitis B Virus Reactivation During Anti–Tumor Necrosis Factor Therapy

Clinical gastroenterology and hepatology, 2023-04, Vol.21 (4), p.1103-1104.e3

2023

Volltextzugriff (PDF)

Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration

World journal of gastroenterology : WJG, 2016-05, Vol.22 (19), p.4732-4740

2016

Volltextzugriff (PDF)

What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? ‘Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus’

Gut, 2018-11, Vol.67 (11), p.1916-1917

2018

Volltextzugriff (PDF)

HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome

Liver international, 2012-10, Vol.32 (9), p.1415-1425

2012

Volltextzugriff (PDF)

Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2013-11, Vol.145 (5), p.1076-1087

2013

Volltextzugriff (PDF)

High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients

Hepatology (Baltimore, Md.), 2011-06, Vol.53 (6), p.1809-1818

2011

Volltextzugriff (PDF)

Hepatitis B surface antibody titres and hepatitis B reactivation with direct‐acting antiviral therapy for hepatitis C

Journal of viral hepatitis, 2021-02, Vol.28 (2), p.373-382

2021

Volltextzugriff (PDF)

Injury pattern recognition to discriminate competing causes of liver injury

Liver international, 2019-05, Vol.39 (5), p.821-825

2019

Volltextzugriff (PDF)

Standard liver tests

Clinical liver disease (Malden, Mass.), 2016-07, Vol.8 (1), p.13-18

2016

Volltextzugriff (PDF)

Current state-of-the-art pharmacotherapy for the management of hepatitis B infection

Expert opinion on pharmacotherapy, 2019-05, Vol.20 (7), p.873-885

2019

Volltextzugriff (PDF)

1 – 25 von 261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(235)
Mit Volltextzugriff
(220)

Publikationsform

Artikel
(245)
Buchkapitel
(11)
Berichte
(4)
Bücher
(1)

Sprache

Englisch
(255)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hepatitis C virus core antigen testing: Role in diagnosis, disease monitoring and treatment

A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)

HLA‐B35:01 and Green Tea–Induced Liver Injury

Death and liver transplantation within 2 years of onset of drug‐induced liver injury

Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin

Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

Antiviral therapy and resistance with hepatitis B virus infection

Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia and Decrease the Need for Ribavirin Dose Reduction

It's not all about the virus-On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B

Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence

Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis

Therapy of Acute and Fulminant Hepatitis B

Trends in mortality from gastrointestinal, hepatic, and pancreatic cancers in the United States: A comprehensive analysis (1999–2020)

Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy

Role of Hepatitis B Surface Antibodies in Risk for Hepatitis B Virus Reactivation During Anti–Tumor Necrosis Factor Therapy

Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration

What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? ‘Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus’

HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome

Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease

High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients

Hepatitis B surface antibody titres and hepatitis B reactivation with direct‐acting antiviral therapy for hepatitis C

Injury pattern recognition to discriminate competing causes of liver injury

Standard liver tests

Current state-of-the-art pharmacotherapy for the management of hepatitis B infection

Suchergebnisse filtern